A very interesting work has been done by Sharda et al. They analyzed the effect of AGP and melatonin combinatorial drug on metastatic colon cancer cell lines (T84, Colo 205, HT-29, and DLD-1) and on a metastatic patient-derived organoid model (PDOD). This evidence concerns the gene ATP5MK and colonic neoplasm.